These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 1833208

  • 1. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C, Stefanini E.
    Eur J Pharmacol; 1991 May 17; 197(2-3):221-3. PubMed ID: 1833208
    [Abstract] [Full Text] [Related]

  • 2. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 17; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 3. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.
    Cross AJ, Mashal RD, Johnson JA, Owen F.
    Neuropharmacology; 1983 Nov 17; 22(11):1327-9. PubMed ID: 6141534
    [Abstract] [Full Text] [Related]

  • 4. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 5. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH, Nielsen EB.
    Acta Pharmacol Toxicol (Copenh); 1986 Oct 02; 59(4):315-8. PubMed ID: 2948372
    [Abstract] [Full Text] [Related]

  • 6. Effect of chronic calcium antagonist treatment on dopamine recognition sites in rat striatum.
    Govoni S, Di Giovine S, Moresco RM, Battaini F, Trabucchi M.
    Neurosci Lett; 1988 Apr 22; 87(1-2):173-7. PubMed ID: 3380334
    [Abstract] [Full Text] [Related]

  • 7. Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats.
    Pani L, Kuzmin A, Stefanini E, Gessa GL, Rossetti ZL.
    Eur J Pharmacol; 1990 Nov 06; 190(1-2):223-7. PubMed ID: 2076754
    [Abstract] [Full Text] [Related]

  • 8. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I, Rinne J, Marjamäki P.
    Pol J Pharmacol; 1999 Nov 06; 51(4):311-6. PubMed ID: 10540962
    [Abstract] [Full Text] [Related]

  • 9. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
    Kirch DG, Taylor TR, Creese I, Xu SX, Wyatt RJ.
    J Pharm Pharmacol; 1992 Feb 06; 44(2):89-92. PubMed ID: 1352822
    [Abstract] [Full Text] [Related]

  • 10. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 11. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA, Bennett JP.
    Brain Res; 1987 Jul 07; 415(1):90-7. PubMed ID: 2957025
    [Abstract] [Full Text] [Related]

  • 12. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb 07; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 13. Effects of estradiol on the ontogenesis of striatal dopamine D1 and D2 receptor sites in male and female rats.
    Ferretti C, Blengio M, Vigna I, Ghi P, Genazzani E.
    Brain Res; 1992 Feb 07; 571(2):212-7. PubMed ID: 1535267
    [Abstract] [Full Text] [Related]

  • 14. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT, Dickman M.
    Invest Ophthalmol Vis Sci; 1992 Apr 07; 33(5):1620-6. PubMed ID: 1532792
    [Abstract] [Full Text] [Related]

  • 15. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M, Dubois A, Benavidès J, Scatton B.
    Neurosci Lett; 1988 Feb 15; 85(1):119-24. PubMed ID: 2834672
    [Abstract] [Full Text] [Related]

  • 16. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Oct 30; 106(1):219-20. PubMed ID: 6241567
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
    Wiener HL, Lajtha A, Sershen H.
    Neuropharmacology; 1989 May 30; 28(5):535-7. PubMed ID: 2657481
    [Abstract] [Full Text] [Related]

  • 18. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M, Dobrovský K, Krejcí I, Dlabac A.
    Act Nerv Super (Praha); 1989 Apr 30; 31(1):77-9. PubMed ID: 2675526
    [No Abstract] [Full Text] [Related]

  • 19. Weanling rats exposed prenatally to cocaine exhibit an increase in striatal D2 dopamine binding associated with an increase in ligand affinity.
    Scalzo FM, Ali SF, Frambes NA, Spear LP.
    Pharmacol Biochem Behav; 1990 Oct 30; 37(2):371-3. PubMed ID: 2150444
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
    Paetsch PR, Greenshaw AJ.
    Cell Mol Neurobiol; 1992 Dec 30; 12(6):597-606. PubMed ID: 1490276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.